Inhibitory effect of NS-398, a selective cyclooxygenase-2 inhibitor, on azoxymethane-induced aberrant crypt foci in colon carcinogenesis of F344 rats

Japanese Journal of Cancer Research

Volumn 88, Issue 11, 1997, Pages 1044-1051

  Yoshimi, Naoki ^a   Kawabata, Kunihiro ^a   Hara, Akira ^a   Matsunaga, Kengo ^a   Yamada, Yasuhiro ^a   Mori, Hideki ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

Chemoprevention; Cyclooxygenase 2; Rat colon carcinogenesis

Indexed keywords

AZOXYMETHANE; CYCLOOXYGENASE 2 INHIBITOR; GUM ARABIC; MESSENGER RNA; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHEMOPROPHYLAXIS; COLON CARCINOGENESIS; COLON MUCOSA; CONTROLLED STUDY; DRUG STRUCTURE; INTESTINE CRYPT; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031451468     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1997.tb00328.x     Document Type: Article

References (46)

1. Broder, S. Perspectives on cancer in Japan and the United States. Jpn. J. Cancer Res., 83, 821-830 (1993).
2. Thun, M. H., Namboodiri, M. and Heath, C. W., Jr. Aspirin use and reduced risk of fatal colon cancer. N. Engl. J. Med., 325, 1593-1596 (1991).
3. Rosenberg, L., Palmer, J. R., Zauner, A. G., Warshauer, M. E., Stolley, P. D. and Shapiro, S. A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of the large-bowel cancer. J. Natl. Cancer Inst., 83, 355-358 (1991).
4. Labyle, D., Fischer, D., Vielh, P., Drouhin, F., Pariente, A., Bories, C., Duhamel, O., Trousset, M. and Attali, P. Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology, 101, 635-639 (1991).
5. Giardiello, F. M., Hamilton, S., Krush, A. J., Piantadosi, S., Hylind, L. M., Celano, P., Booker, S. V., Robinson, C. R. and Offerhaus, G. J. Treatment of colonie and rectal adenoma with sulindac in familial adenomatous polyposis. N. Engl. J. Med., 328, 1313-1316 (1993).
6. Reddy, B. S., Rao, C. V., Rivenson, A. and Kelloff, G. Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats. Carcinogenesis, 14, 1493-1497 (1993).
7. Reddy, B. S., Maruyama, H. and Kelloff, G. Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal anti-inflammatory drug, during different stages of rat colon tumor development. Cancer Res., 47, 5340-5346 (1987).
8. Rao, C. V., Rivenson, A., Simi, B., Zang, E., Kelloff, G., Steele, V. and Reddy, B. S. Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent. Cancer Res., 55, 1464-1472 (1995).
9. Tanaka, T., Kojima, T., Yoshimi, N., Sugie, S. and Mori, H. Inhibitory effect of the non-steroidal anti-inflammatory drug, indomethacin on the naturally occurring carcinogen, 1-hydroxyanthraquinone in male ACI/N rats. Carcinogenesis, 12, 1949-1952 (1991).
10. Craven, P. A., Satio, R. and DeRubertis, F. R. Role of local prostaglandin synthesis in the modulation of proliferative activity of rat colonic epithelium. J. Clin. Invest., 72, 1365-1375 (1983).
11. Rigas, B., Goldman, I. S. and Levine, L. Altered eicosanoid levels in human colon cancer. J. Lab. Clin. Med., 122, 518-523 (1993).
12. Yamaguchi, A., Iishida, T., Nishimura, G., Katoh, M. and Miyazaki, I. Investigation of colonic prostaglandins in carcinogenesis in the rat colon. Dis. Colon Rectum, 34, 572-576 (1991).
13. Smith, W. L. and Marnett, L. Prostaglandin endoperoxide synthase: structure and catalysis. Biochim. Biophys. Acta, 1083, 1-17 (1991).
14. Feng, L., Sun, W., Xia, Y., Tang, W. W., Chanmugam, P., Soyoola, E., Wilson, C. B. and Hwang, D. Cloning two isoforms of rat cyclooxygenase: differential regulation of their expression. Arch. Biochem. Biophys., 307, 361-368 (1993).
15. 2 synthase in the endothelium and smooth muscle of bovine aorta. J. Clin. Invest., 72, 1882-1888 (1983).
16. Kujubu, D. A., Fletcher, B. S., Varnum, B. C., Lim, R. W. and Herschman, H. R. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J. Biol. Chem., 266, 12866-12872 (1991).
17. Hla, T. and Neilson, K. Human cyclooxygenase-2 cDNA. Proc. Natl. Acad. Sci. USA, 89, 7384-7388 (1992).
18. Hla, T., Kistimaki, A., Appleby, S. and Barriocanel, J. G. Cyclooxygenase gene expression in inflammation and angiogenesis. Ann. NY Acad. Sci., 696, 197-204 (1993).
19. Eberhart, C. E., Coffey, R. J., Radhika, A., Giardiello, F. M., Ferrenbach, S. and Dubois, R. N. Up-regulation of cyclooxygenase-2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology, 107, 1183-1188 (1994).
20. Kargman, S. L., O'Neill, G. P., Vickers, P. J., Evans, J. F., Mancini, J. A. and Jothy, S. Expression of prostaglandin G/H syntheses-1 and -2 protein in human colon cancer. Cancer Res., 55, 2556-2559 (1995).
21. Sano, H., Kawahito, Y., Wilder, R. L. Hashiramoto, A., Mukai, S., Asai, K., Kimura, S., Kato, H., Kondo, M. and Hla, T. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res., 55, 3785-3789 (1995).
22. 2 and cyclooxygenase, in the large bowel mucosa and neoplasms of F344 rats treated with naturally occurring carcinogen, 1-hydroxyanthraquinone. Cancer Lett., 97, 75-82 (1995).
23. Futaki, N., Arai, I., Hamasaka, Y., Takahashi, S., Higuchi, S. and Otomo, S. Selective inhibition of NS-398 on prostanoid production in inflamed tissue in rat carrageenan-air-pouch inflammation. J. Pharm. Pharmacol., 45, 753-755 (1993).
24. Parnham, M. J. Inflammation '93. Drug News Perspect., 6, 737-742 (1994).
25. Futaki, N., Takahashi, S., Yokoyama, M., Arai, S., Higuchi, S. and Otomo, S. NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins, 47, 55-59 (1994).
26. Takahashi, M., Fukutake, M., Yokota, S., Ishida, K., Wakabayashi, K. and Sugimura, T. Suppression of azoxy-methane-induced aberrant crypt foci in rat colon by nimesulide, a selective inhibitor of cyclooxygenase-2. J. Cancer Res. Clin. Oncol., 122, 219-222 (1996).
27. Reddy, B. S., Rao, C. V. and Seibert, K. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res., 56, 4566-4569 (1996).
28. Bird, R. P. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett., 37, 147-151 (1987).
29. Kawamori, T., Tanaka, T., Ohnishi, M., Hirose, Y., Nakamura, Y., Satoh, K., Hara, A. and Mori, H. Chemoprevention of azoxymethane-induced colon carcinogenesis by dietary feeding of S-methylmethane thiosulfonate in male F344 rats. Cancer Res., 55, 4053-4058 (1995).
30. Wang, A., Yoshimi, N., Tanaka, T. and Mori, H. Inhibitory effects of magnesium hydroxide on c-myc expression and cell proliferation induced by methylazoxymethanol acetate in rat colon. Cancer Lett., 775, 73-78 (1993).
31. Mori, H., Mori, Y., Tanaka, T., Yoshimi, N., Sugie, S., Kawamori, T. and Narisawa, T. Cell kinetic analysis of the mucosal epithelium and assay of ornithine decarboxylase activity during the process of 1-hydroxyanthraquinone-induced large bowel carcinogenesis in rats. Carcinogenesis, 13, 2217-2220 (1992).
32. Chromczynski, P. and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159 (1987).
33. Yoshimi, N., Sato, S., Makita, H., Wang, A., Hirose, Y., Tanaka, T. and Mori, H. Expression of cytokines, TNF-α and IL-1α, in MAM acetate and 1-hydroxyanthraquinone-induced colon carcinogenesis of rats. Carcinogenesis, 15, 783-785 (1994).
34. Nudel, U., Zakut, R., Shani, M., Neuman, S., Levy, Z. and Yaffe, D. The nucleotide sequence of the rat cytoplasmic beta-actin gene. Nucleic Acids Res., 11, 1759-1771 (1983).
35. Dothwaite, A. H. and Lintott, G. A. M. Gastroscopic observation of the effect of aspirin and certain other substances on the stomach. Lancet, 292, 1191-1192 (1938).
36. Corwin, H. G. and Bonventre, J. V. Renal insufficiency associated with non-steroidal antiinflammatory agents. Am. J. Kidney Dis., 4, 147-152 (1984).
37. Pairet, M. and Engelhardt, G. Differential inhibition of COX-1 and COX-2 in vitro and pharmacological profile in vivo of NSAIDs. In "Improved Non-steroidal Anti-inflammatory Drugs: COX-2 Enzyme Inhibitors," ed. J. Vane, J. Sotting and R. Botting, pp. 103-119 (1996). Kluwer Academic Publishers, Dordrecht.
38. Wallace, J. L., Keena, K. M. and Granger, D. N. Gastric ulceration induced by nonsteroidal anti-inflammatory drugs is a neurophil-dependent process. Am. J. Physiol., 259, G462-G467 (1990).
39. Carmichael, J. and Shankel, S. Effects of nonsteroidal anti-inflammatory drugs on prostaglandins and renal function. Am. J. Med., 78, 992-1000 (1985).
40. Tsujii, M. and DuBois, R. N. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell, 83, 493-501 (1995).
41. Patrono, C., Patrignani, P., Panara, M. R., Cipollone, F., Santini, G., Sciulli, M. G., Rotondo, M. T., Padovano, R. and DiGiamberardino, M. COX-2 expression and inhibition in human monocytes. In "Improved Non-steroidal Anti-inflammatory Drugs: COX-2 Enzyme Inhibitors,"ed. J. Vane, J. Botting and R. Botting, pp. 121-131 (1996). Kluwer Academic Publishers, Dordrecht.
42. Piazza, G. A., Rahm, A. L., Krutzsch, M., Sperl, G., Paranka, N. S., Gross, P. H., Brendel, K., Burt, R. W., Alberts, D. S., Pamukcu, R. and Ahnen, D. J. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Res., 55, 3110-3116 (1995).
43. Elder, D. J., Hague, A., Hicks, D. J. and Paraskeva, C. Differential growth inhibition by the aspirin metabolite salicylate in human colorectal tumor cell lines: enhanced apoptosis in carcinoma and in vitro-transformed adenoma relative to adenoma cell lines. Cancer Res., 56, 2273-2276 (1996).
44. Shiff, S. J., Koutsos, M. L, Qiao, L. and Rigas, B. Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: effects on cell cycle and apoptosis. Exp. Cell Res., 222, 179-188 (1996).
45. Hara, A., Yoshimi, N., Niwa, M., Ino, N. and Mori, H. Apoptosis induced by NS-398, a selective cyclooxygenase-2 inhibitor, in human colorectal cancer cell lines. Jpn. J. Cancer Res., 88, 600-604 (1997).
46. DuBois, R. N., Shao, J., Tsujii, M., Sheng, H. and Beauchamp, R. D. G1 delay in cells overexpressing prostaglandin endoperoxide synthase-2. Cancer Res., 56, 733-737 (1996).